Movatterモバイル変換


[0]ホーム

URL:


News & Perspective
Drugs & Diseases
CME & Education
Video
Decision Point

Specialty:Multispecialty
Edition:English
Log In
Sign Up It's Free!
English Edition

Medscape

Univadis

    X
    UnivadisfromMedscape
    RegisterLog In

    No Results

      No Results

        Friday, April 11, 2025
        News & PerspectiveDrugs & DiseasesCME & EducationVideoDecision Point
        close
        Please confirm that you would like to log out of Medscape.If you log out, you will be required to enter your username and password the next time you visit.Log outCancel

        Contact Allergen of the Year: Corticosteroids

        Marléne Isaksson; Magnus Bruze

        Disclosures

        Dermatitis. 2005;16(1):3-5. 

        In This Article

        Introduction

        Corticosteroids still constitute the main armamentarium for the symptomatic treatment of inflammatory skin diseases. One drawback that has been recognized during the last 10 to 15 years is hypersensitivity to these substances; delayed-type hypersensitivity is by far the most common, but type I allergy has also been observed. Routine patch testing with one or two corticosteroids in consecutively tested dermatitis patients has detected a fairly high frequency of hypersensitivity to corticosteroids after topical as well as systemic administration; figures of up to 5% have been presented.[1,2,3,4,5] The three aspects of corticosteroid contact allergy that we wish to focus on here must be considered; otherwise, the risk of missing such allergy may be significantly increased.

          Dermatitis. 2005;16(1):3-5. © 2005 American Contact Dermatitis Society

          Cite this: Contact Allergen of the Year: Corticosteroids - Medscape - Mar 01, 2005.

          Tables
          References
          Authors and Disclosures

          Authors and Disclosures

          Marléne Isaksson ;Magnus Bruze , Department of Occupational and Environmental Dermatology, Malmö University Hospital, Malmö, Sweden

          Comments

          3090D553-9492-4563-8681-AD288FA52ACE
          Commenting is limited to medical professionals. To comment pleaseLog-in.
          Comments on Medscape are moderated and should be professional in tone and on topic. You must declare any conflicts of interest related to your comments and responses. Please see ourCommenting Guide for further information. We reserve the right to remove posts at our sole discretion.
          Comments on Medscape are moderated and should be professional in tone and on topic. You must declare any conflicts of interest related to your comments and responses. Please see ourCommenting Guide for further information. We reserve the right to remove posts at our sole discretion.
          My Alerts

          You have already selected for My Alerts

          Click the topic below to receive emails when new articles are available.

           

          You've successfully added to your alerts. You will receive email when new content is published.

          Share
          Facebook
          Twitter
          LinkedIn
          WhatsApp
          Email
          Close
          Print
          Add to Email Alerts

          processing....

          Email This
          Feedback
          Help us make reference on Medscape the best clinical resource possible.Please use this form to submit your questions or comments on how to make this article more useful to clinicians.
          Pleasedo not use this form to submit personal or patient medical information or to report adverse drug events. You are encouraged to report adverse drug event information to the FDA.
          Your Name is required.
          Subject is required.
          Please enter a Recipient Address and/or check the Send me a copy checkbox.
          Your email has been sent.
          is an Invalid Email Address.
          Medscape Logo
          Find Us On
          About
          About MedscapePrivacy PolicyEditorial PolicyCookiesManage PreferencesTerms of UseAdvertising PolicyHelp Center
          Membership
          Become a MemberAbout YouProfessional InformationNewsletters & AlertsAdvertiseMarket Research
          Medscape
          Editions
          EnglishDeutschEspañolFrançaisPortuguês
          All material on this website is protected by copyright, Copyright © 1994-2025 by WebMD LLC. This website also contains material copyrighted by 3rd parties.

          [8]ページ先頭

          ©2009-2025 Movatter.jp